Silo Pharma, Inc. (NASDAQ:SILO) Sees Large Decrease in Short Interest

Silo Pharma, Inc. (NASDAQ:SILO) saw a large drop in short interest in the month of August. As of August 31st, there was short interest totalling 134,100 shares, a drop of 25.4% from the August 15th total of 179,700 shares. Based on an average daily volume of 5,040,000 shares, the days-to-cover ratio is presently 0.0 days. Currently, 3.1% of the company’s stock are short sold.

Silo Pharma Trading Up 1.9 %

NASDAQ SILO traded up $0.02 during trading hours on Friday, reaching $1.10. 89,791 shares of the company’s stock traded hands, compared to its average volume of 293,084. Silo Pharma has a 52-week low of $0.84 and a 52-week high of $4.50. The firm has a 50-day simple moving average of $1.53 and a 200 day simple moving average of $1.62.

Silo Pharma (NASDAQ:SILO) last released its earnings results on Tuesday, August 13th. The company reported ($0.31) EPS for the quarter. Silo Pharma had a negative return on equity of 55.30% and a negative net margin of 4,881.57%. The company had revenue of $0.02 million during the quarter.

Silo Pharma Company Profile

Silo Pharma. Inc, a developmental stage biopharmaceutical company, develops traditional therapeutics and psychedelic medicine. Its lead program includes SPC-15, an intranasal drug targeting post-traumatic stress disorder (PTSD) and stress-induced anxiety disorders; and SP-26, a ketamine-based loaded implant indicated for fibromyalgia and chronic pain relief.